1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application, End Users (Hospitals) – Forecast Till 2023

Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application, End Users (Hospitals) – Forecast Till 2023

  • June 2018
  • 137 pages
  • ID: 5713546
  • Format: PDF
  • By Market Research Future

Summary

Table of Contents

Introduction

The needle-free injection system is a novel technique used to introduce medicines to patients without piercing the skin with conventional needles. This technology offers the benefit of reducing patient concern about the use of needles. These injections are very effective for a wide range of drugs and results in less pain and hence are strongly preferred by patients. Additional benefits of these needle-free injections include fast results as compared to conventional needles and no issue of needle disposal. This technique could be used to administer vaccines and medications in the pork industry. The rising prevalence of various chronic diseases is propelling the need for needle-free injections. Increase in investments in the pharmaceutical sector and convenient use of these medical devices in home care are projected to drive market growth over the forecast period.

However, the high cost of these devices, strict regulatory bodies, and stringent regulatory policies are expected to restrain market growth during the forecast period.

The global needle-free injection market has been segmented, by product, technology, usability, type of medication, site of delivery, application, and end user.
Based on product type, the global needle-free injection market has been categorized as fillable needle-free injectors and prefilled needle-free injectors.

On the basis of technology, the global needle-free injection market is further sub-segmented into jet-based, spring-based, and laser-powered.

By usability, the global needle-free injection market is further sub-segmented into reusable needle-free injectors and disposable needle-free injectors.

The global needle-free injection market by type of medication is further sub-segmented into liquid-based needle-free injectors, powder-based needle-free injectors, and projectile/depot-based needle-free injectors.
On the basis of site of delivery, the global needle-free injection market is further sub-segmented into intradermal injectors, intramuscular injectors, and subcutaneous injectors.

By application, the global needle-free injection market is further sub-segmented into vaccination, insulin delivery, and oncology.

On the basis of end user, the market has been classified as hospitals and clinics, ambulatory surgical centers, and home care settings.

The global needle-free injection market was valued at USD 10,377.7 million in 2017 and is expected to register a CAGR of 15.28 % during the forecast period from 2017 to 2023.

Key Players

Some of the key players in the global needle-free injection market are Antares Pharma Inc., Endo Pharmaceuticals Inc., PharmaJet Inc., Inovio Pharmaceuticals Inc., Medical International Technology Inc., INJEX Pharma GmBH, National Medical Products Inc, European Pharma Group, PenJet Corporation, Valeritas Holdings Inc, Crossject, Mika Medical Co., and D’Antonio Consultants International Inc.

Objectives of the Study

• To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global needle-free injection market
• To provide insights into factors influencing and affecting market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global needle-free injection market
• To provide a detailed analysis of the value chain and supply chain of the global needle-free injection market

Target Audience

• Government Research Institutes
• Research and Development (R&D) Companies
• Medical Devices Companies
• Academic Institutes and Universities

Key Findings

• The global needle-free injection market is expected to reach USD 25,057.4 million by 2023 at a CAGR of 15.28 % from 2017 to 2023
• Based on technology, the jet-based needle-free injectors segment holds the largest market share and is expected to reach USD 10,391.3 million by 2023 at a CAGR of 15.90% from 2017 to 2023
• The market in the Americas is expected to account for the largest share of the global needle-free injection market and is projected to reach USD 8,750.7 million by 2023
• The needle-free injection market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 15.74 % from 2017 to 2023

Regional Analysis

• Americas
o North America
US
Canada
o Latin America
• Europe
o Western Europe
Germany
France
UK
Italy
Spain
Rest of Western Europe
o Eastern Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

Companies Mentioned

Antares Pharma Inc
Endo Pharmaceuticals Inc
PharmaJet, Inc
Inovio Pharmaceuticals Inc
Medical International Technology, Inc
INJEX Pharma GmBH
National Medical Products Inc
European Pharma Group
PenJet Corporation
Valeritas Holdings, Inc
CROSSJECT
MIKA MEDICAL CO
D’Antonio Consultants International, Inc

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Amniocentesis Needle Industry

Global Amniocentesis Needle Industry

  • $ 4950
  • October 2019

Amniocentesis Needle market worldwide is projected to grow by US$31.4 Million, driven by a compounded growth of 2.7%. Smaller than 100 mm, one of the segments analyzed and sized in this study, displays ...

Smart Syringes Market to 2027 - Global Analysis and Forecasts By Type ; Application ; End User and Geography

Smart Syringes Market to 2027 - Global Analysis and Forecasts By Type ; Application ; End User and Geography

  • $ 4550
  • August 2019

The global smart syringes market is expected to reach US$ 14,431.33 Mn in 2027 from US$ 5,911.82 in 2018. The market is estimated to grow with a CAGR of 10.6% from 2019-2027.The key factors such as rising ...

Global Injectable Drugs Delivery Industry

Global Injectable Drugs Delivery Industry

  • $ 5450
  • October 2019

Injectable Drugs Delivery market worldwide is projected to grow by US$423.4 Billion, driven by a compounded growth of 11%. Device, one of the segments analyzed and sized in this study, displays the potential ...

Global Autoinjectors Industry $ 4950 October 2019

Global Needles Industry $ 4950 October 2019

Global Pen Needles Industry $ 5450 October 2019


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on